These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22989484)

  • 21. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
    Hori YS; Kuno A; Hosoda R; Horio Y
    PLoS One; 2013; 8(9):e73875. PubMed ID: 24040102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
    Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
    Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
    Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
    Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
    Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mannose receptor C type 2 mediates 1,25(OH)
    Dong Y; Yang L; Luo W; Zhu T; Yan W; Kong J; Yuan Z; Zhao Q
    Mol Cell Endocrinol; 2019 Mar; 483():74-86. PubMed ID: 30641101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter.
    Hines ER; Kolek OI; Jones MD; Serey SH; Sirjani NB; Kiela PR; Jurutka PW; Haussler MR; Collins JF; Ghishan FK
    J Biol Chem; 2004 Nov; 279(45):46406-14. PubMed ID: 15337762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
    Gao F; Wang W
    Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
    Kanatani M; Sugimoto T; Fukase M; Chihara K
    Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
    Curtis KM; Aenlle KK; Roos BA; Howard GA
    Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
    Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
    Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
    Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
    Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.